The Drug Coated Balloon Club meeting

DCB 2026

20th & 21st November 2026 - BERLIN, GERMANY

Dedicated to sharing knowledge, improving the safety and efficacy of Drug Coated Balloon use.

“Drug-Coated Balloons in Contemporary PCI – From Science to Practice”

Meeting Objectives

Understand the pathophysiology of CAD based on intravascular imaging and physiology.
Learn why and how DCB technology is reshaping PCI strategy for the future.
Exchange interpretations and implications of recent major clinical trials on DCB.
Communicate current research needs and discuss future investigative requirements.The DCB Club will delve into the multitude of unanswered questions, dive into contentious debates, and track the rapid evolution of evidence in this captivating realm.

‘The DCB Club is not just a meeting of like minded experts…

it's a driving force for positive change in DCB education & treatment’.

Join us in our commitment to promoting best practices, fostering collaboration, and ultimately improving patient outcomes.

Together, we can shape the future of DCB education & treatment.

The DCB Club 2026 – Berlin, Germany
“Drug-Coated Balloons in Contemporary PCI – From Science to Practice”

The Drug-Coated Balloon (DCB) Club returns to Berlin in November 2026, bringing together global experts in interventional cardiology for an immersive two-day programme focused on advancing the science and clinical application of DCB technology in percutaneous coronary intervention (PCI). Designed for experienced operators and opinion leaders, this year’s meeting explores how DCBs are reshaping the future of PCI—from initial lesion assessment to long-term patient outcomes.

Structured around cutting-edge scientific sessions, the agenda dives deep into the pathophysiology of coronary artery disease, the evolution of DCB technologies, and the strategic considerations for their use in various complex lesion subsets including bifurcations, CTOs, high-bleeding-risk patients, and STEMI/NSTEMI scenarios.

Attendees will engage with the latest clinical trial data, explore contemporary imaging and lesion preparation techniques, and discuss drug selection, hybrid strategies, and emerging alternatives like bioresorbable scaffolds. The meeting also emphasizes open dialogue through focused Q&A, breakout sessions with industry, and collaborative consensus-building—culminating in a forward-looking discussion on future research needs and key messages for a DCB consensus paper.

Led by pioneers in the field such as Bruno Scheller, Franz Kleber, Raban Jeger, Victor Jimenez, Simon Eccleshall, Ulf Landmesser & Fernando Alfonso, the DCB Club is more than a scientific forum—it’s a collaborative platform driving innovation and best practice in DCB-based PCI.